United States Facial Injectables Market Report 2018

Publisher Name :
Date: 21-Mar-2018
No. of pages: 110
Inquire Before Buying

In this report, the United States Facial Injectables market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Facial Injectables in these regions, from 2013 to 2025 (forecast).

United States Facial Injectables market competition by top manufacturers/players, with Facial Injectables sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Allergan

- Prollenium Medical Technologies Inc

- Galderma

- Merz Aesthetics

- Ipsen Group

- Bloomage BioTechnology

- Hangzhou Techderm Biological Products

- Laboratory Obvieline

- Medytox

- Polymekon

- Qufu Guanglong Biochem

- Revitacare

- Suneva Medical

- SciVision Biotech

- Speciality European Pharma

- Syneron

- Visionmed

- AQTIS Medical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Botulinum Toxin

- Hyaluronic Acid

- Collagen

- Particle & Polymer Fillers (PPF)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Hospitals

- Ambulatory Surgical Centers

- Cosmetic Centers

- Dermatology Clinics

- Physician Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Facial Injectables Market Report 2018

Table of Contents
United States Facial Injectables Market Report 2018
1 Facial Injectables Overview
1.1 Product Overview and Scope of Facial Injectables
1.2 Classification of Facial Injectables by Product Category
1.2.1 United States Facial Injectables Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Facial Injectables Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Botulinum Toxin
1.2.4 Hyaluronic Acid
1.2.5 Collagen
1.2.6 Particle & Polymer Fillers (PPF)
1.3 United States Facial Injectables Market by Application/End Users
1.3.1 United States Facial Injectables Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Cosmetic Centers
1.3.5 Dermatology Clinics
1.3.6 Physician Clinics
1.4 United States Facial Injectables Market by Region
1.4.1 United States Facial Injectables Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Facial Injectables Status and Prospect (2013-2025)
1.4.3 Southwest Facial Injectables Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Facial Injectables Status and Prospect (2013-2025)
1.4.5 New England Facial Injectables Status and Prospect (2013-2025)
1.4.6 The South Facial Injectables Status and Prospect (2013-2025)
1.4.7 The Midwest Facial Injectables Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Facial Injectables (2013-2025)
1.5.1 United States Facial Injectables Sales and Growth Rate (2013-2025)
1.5.2 United States Facial Injectables Revenue and Growth Rate (2013-2025)
2 United States Facial Injectables Market Competition by Players/Suppliers
2.1 United States Facial Injectables Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Facial Injectables Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Facial Injectables Average Price by Players/Suppliers (2013-2018)
2.4 United States Facial Injectables Market Competitive Situation and Trends
2.4.1 United States Facial Injectables Market Concentration Rate
2.4.2 United States Facial Injectables Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Facial Injectables Manufacturing Base Distribution, Sales Area, Product Type
3 United States Facial Injectables Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Facial Injectables Sales and Market Share by Region (2013-2018)
3.2 United States Facial Injectables Revenue and Market Share by Region (2013-2018)
3.3 United States Facial Injectables Price by Region (2013-2018)
4 United States Facial Injectables Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Facial Injectables Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Facial Injectables Revenue and Market Share by Type (2013-2018)
4.3 United States Facial Injectables Price by Type (2013-2018)
4.4 United States Facial Injectables Sales Growth Rate by Type (2013-2018)
5 United States Facial Injectables Sales (Volume) by Application (2013-2018)
5.1 United States Facial Injectables Sales and Market Share by Application (2013-2018)
5.2 United States Facial Injectables Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Facial Injectables Players/Suppliers Profiles and Sales Data
6.1 Allergan
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Facial Injectables Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Allergan Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Prollenium Medical Technologies Inc
6.2.2 Facial Injectables Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Prollenium Medical Technologies Inc Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Galderma
6.3.2 Facial Injectables Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Galderma Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Merz Aesthetics
6.4.2 Facial Injectables Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merz Aesthetics Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Ipsen Group
6.5.2 Facial Injectables Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Ipsen Group Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Bloomage BioTechnology
6.6.2 Facial Injectables Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bloomage BioTechnology Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Hangzhou Techderm Biological Products
6.7.2 Facial Injectables Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Hangzhou Techderm Biological Products Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Laboratory Obvieline
6.8.2 Facial Injectables Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Laboratory Obvieline Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Medytox
6.9.2 Facial Injectables Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Medytox Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Polymekon
6.10.2 Facial Injectables Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Polymekon Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Qufu Guanglong Biochem
6.12 Revitacare
6.13 Suneva Medical
6.14 SciVision Biotech
6.15 Speciality European Pharma
6.16 Syneron
6.17 Visionmed
6.18 AQTIS Medical
7 Facial Injectables Manufacturing Cost Analysis
7.1 Facial Injectables Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Facial Injectables
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Facial Injectables Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Facial Injectables Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Facial Injectables Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Facial Injectables Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Facial Injectables Sales Volume Forecast by Type (2018-2025)
11.3 United States Facial Injectables Sales Volume Forecast by Application (2018-2025)
11.4 United States Facial Injectables Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Facial Injectables
Figure United States Facial Injectables Market Size (K Doses) by Type (2013-2025)
Figure United States Facial Injectables Sales Volume Market Share by Type (Product Category) in 2017
Figure Botulinum Toxin Product Picture
Figure Hyaluronic Acid Product Picture
Figure Collagen Product Picture
Figure Particle & Polymer Fillers (PPF) Product Picture
Figure United States Facial Injectables Market Size (K Doses) by Application (2013-2025)
Figure United States Sales Market Share of Facial Injectables by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Ambulatory Surgical Centers Examples
Table Key Downstream Customer in Ambulatory Surgical Centers
Figure Cosmetic Centers Examples
Table Key Downstream Customer in Cosmetic Centers
Figure Dermatology Clinics Examples
Table Key Downstream Customer in Dermatology Clinics
Figure Physician Clinics Examples
Table Key Downstream Customer in Physician Clinics
Figure United States Facial Injectables Market Size (Million USD) by Region (2013-2025)
Figure The West Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Facial Injectables Sales (K Doses) and Growth Rate (2013-2025)
Figure United States Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Facial Injectables Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table United States Facial Injectables Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table United States Facial Injectables Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Facial Injectables Sales Share by Players/Suppliers
Figure 2017 United States Facial Injectables Sales Share by Players/Suppliers
Figure United States Facial Injectables Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Facial Injectables Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Facial Injectables Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Facial Injectables Revenue Share by Players/Suppliers
Figure 2017 United States Facial Injectables Revenue Share by Players/Suppliers
Table United States Market Facial Injectables Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Facial Injectables Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Facial Injectables Market Share of Top 3 Players/Suppliers
Figure United States Facial Injectables Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Facial Injectables Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Facial Injectables Product Category
Table United States Facial Injectables Sales (K Doses) by Region (2013-2018)
Table United States Facial Injectables Sales Share by Region (2013-2018)
Figure United States Facial Injectables Sales Share by Region (2013-2018)
Figure United States Facial Injectables Sales Market Share by Region in 2017
Table United States Facial Injectables Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Facial Injectables Revenue Share by Region (2013-2018)
Figure United States Facial Injectables Revenue Market Share by Region (2013-2018)
Figure United States Facial Injectables Revenue Market Share by Region in 2017
Table United States Facial Injectables Price (USD/Dose) by Region (2013-2018)
Table United States Facial Injectables Sales (K Doses) by Type (2013-2018)
Table United States Facial Injectables Sales Share by Type (2013-2018)
Figure United States Facial Injectables Sales Share by Type (2013-2018)
Figure United States Facial Injectables Sales Market Share by Type in 2017
Table United States Facial Injectables Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Facial Injectables Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Facial Injectables by Type (2013-2018)
Figure Revenue Market Share of Facial Injectables by Type in 2017
Table United States Facial Injectables Price (USD/Dose) by Types (2013-2018)
Figure United States Facial Injectables Sales Growth Rate by Type (2013-2018)
Table United States Facial Injectables Sales (K Doses) by Application (2013-2018)
Table United States Facial Injectables Sales Market Share by Application (2013-2018)
Figure United States Facial Injectables Sales Market Share by Application (2013-2018)
Figure United States Facial Injectables Sales Market Share by Application in 2017
Table United States Facial Injectables Sales Growth Rate by Application (2013-2018)
Figure United States Facial Injectables Sales Growth Rate by Application (2013-2018)
Table Allergan Basic Information List
Table Allergan Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Allergan Facial Injectables Sales Growth Rate (2013-2018)
Figure Allergan Facial Injectables Sales Market Share in United States (2013-2018)
Figure Allergan Facial Injectables Revenue Market Share in United States (2013-2018)
Table Prollenium Medical Technologies Inc Basic Information List
Table Prollenium Medical Technologies Inc Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Prollenium Medical Technologies Inc Facial Injectables Sales Growth Rate (2013-2018)
Figure Prollenium Medical Technologies Inc Facial Injectables Sales Market Share in United States (2013-2018)
Figure Prollenium Medical Technologies Inc Facial Injectables Revenue Market Share in United States (2013-2018)
Table Galderma Basic Information List
Table Galderma Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Galderma Facial Injectables Sales Growth Rate (2013-2018)
Figure Galderma Facial Injectables Sales Market Share in United States (2013-2018)
Figure Galderma Facial Injectables Revenue Market Share in United States (2013-2018)
Table Merz Aesthetics Basic Information List
Table Merz Aesthetics Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merz Aesthetics Facial Injectables Sales Growth Rate (2013-2018)
Figure Merz Aesthetics Facial Injectables Sales Market Share in United States (2013-2018)
Figure Merz Aesthetics Facial Injectables Revenue Market Share in United States (2013-2018)
Table Ipsen Group Basic Information List
Table Ipsen Group Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Ipsen Group Facial Injectables Sales Growth Rate (2013-2018)
Figure Ipsen Group Facial Injectables Sales Market Share in United States (2013-2018)
Figure Ipsen Group Facial Injectables Revenue Market Share in United States (2013-2018)
Table Bloomage BioTechnology Basic Information List
Table Bloomage BioTechnology Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bloomage BioTechnology Facial Injectables Sales Growth Rate (2013-2018)
Figure Bloomage BioTechnology Facial Injectables Sales Market Share in United States (2013-2018)
Figure Bloomage BioTechnology Facial Injectables Revenue Market Share in United States (2013-2018)
Table Hangzhou Techderm Biological Products Basic Information List
Table Hangzhou Techderm Biological Products Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Hangzhou Techderm Biological Products Facial Injectables Sales Growth Rate (2013-2018)
Figure Hangzhou Techderm Biological Products Facial Injectables Sales Market Share in United States (2013-2018)
Figure Hangzhou Techderm Biological Products Facial Injectables Revenue Market Share in United States (2013-2018)
Table Laboratory Obvieline Basic Information List
Table Laboratory Obvieline Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Laboratory Obvieline Facial Injectables Sales Growth Rate (2013-2018)
Figure Laboratory Obvieline Facial Injectables Sales Market Share in United States (2013-2018)
Figure Laboratory Obvieline Facial Injectables Revenue Market Share in United States (2013-2018)
Table Medytox Basic Information List
Table Medytox Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Medytox Facial Injectables Sales Growth Rate (2013-2018)
Figure Medytox Facial Injectables Sales Market Share in United States (2013-2018)
Figure Medytox Facial Injectables Revenue Market Share in United States (2013-2018)
Table Polymekon Basic Information List
Table Polymekon Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Polymekon Facial Injectables Sales Growth Rate (2013-2018)
Figure Polymekon Facial Injectables Sales Market Share in United States (2013-2018)
Figure Polymekon Facial Injectables Revenue Market Share in United States (2013-2018)
Table Qufu Guanglong Biochem Basic Information List
Table Revitacare Basic Information List
Table Suneva Medical Basic Information List
Table SciVision Biotech Basic Information List
Table Speciality European Pharma Basic Information List
Table Syneron Basic Information List
Table Visionmed Basic Information List
Table AQTIS Medical Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Facial Injectables
Figure Manufacturing Process Analysis of Facial Injectables
Figure Facial Injectables Industrial Chain Analysis
Table Raw Materials Sources of Facial Injectables Major Players/Suppliers in 2017
Table Major Buyers of Facial Injectables
Table Distributors/Traders List
Figure United States Facial Injectables Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Facial Injectables Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Facial Injectables Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Facial Injectables Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Type in 2025
Table United States Facial Injectables Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Application in 2025
Table United States Facial Injectables Sales Volume (K Doses) Forecast by Region (2018-2025)
Table United States Facial Injectables Sales Volume Share Forecast by Region (2018-2025)
Figure United States Facial Injectables Sales Volume Share Forecast by Region (2018-2025)
Figure United States Facial Injectables Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Chronic Urticaria Or Hives - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 77
    Chronic Urticaria Or Hives - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Urticaria Or Hives - Pipeline Review, H2 2018, provides an overview of the Chronic Urticaria Or Hives (Dermatology) pipeline landscape. Chronic urticaria also known as hives, are an outbreak of swollen, pale red bumps, patches, or welts on the skin that appear suddenly either as a result of allergies......
  • Epidermolysis Bullosa - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 122
    Epidermolysis Bullosa - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa - Pipeline Review, H2 2018, provides an overview of the Epidermolysis Bullosa (Dermatology) pipeline landscape. Epidermolysis bullosa (EB) is a group of inherited bullous disorders characterized by blister formation in response to mechanical trauma. Symptoms include blistering of skin, defor......
  • Vitiligo - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 102
    Vitiligo - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vitiligo - Pipeline Review, H2 2018, provides an overview of the Vitiligo (Dermatology) pipeline landscape. Vitiligo is a condition in which skin loses melanin, the pigment that determines the color of skin, hair and eyes. Symptoms include premature whitening or graying of the hair on scalp, eyelashes, eyebrows or beard, loss......
  • Rosacea - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 66
    Rosacea - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rosacea - Pipeline Review, H2 2018, provides an overview of the Rosacea (Dermatology) pipeline landscape. Rosacea is a chronic and potentially life-disruptive disorder primarily of the facial skin, often characterized by flare-ups and remissions. Symptoms include frequent redness of the face, or flushing, small, red lines unde......
  • Acne Vulgaris - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 186
    Acne Vulgaris - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acne Vulgaris - Pipeline Review, H2 2018, provides an overview of the Acne Vulgaris (Dermatology) pipeline landscape. Acne vulgaris is a chronic skin disease involving blockage and inflammation of pilosebaceous follicles. Symptoms include crusting of skin bumps, cysts, papules (small red bumps), scarring of the skin and ......
  • Global Dermal Filler Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Oct-2018        Price: US 3480 Onwards        Pages: 135
    Dermal filler is an injectable drug used to diminish facial lines and restore volume and fullness in the face. It is used to plump thin lips, soften facial creases and wrinkles, enhance shallow contours, and improve the appearance of recessed scars. One of the aspects of modern life, which is considered as essential by men as well as women is appearance. The urge to look as good as they feel has led to the notable growth in the cosmetology industry. Scope of the Report: ......
  • Global Dermatological Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 12-Oct-2018        Price: US 3480 Onwards        Pages: 130
    Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others. Scope of the Report: This report focuses on the Dermatological Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Different tech......
  • Global Facial Injectables Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Oct-2018        Price: US 3480 Onwards        Pages: 148
    Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore collagen lost due to aging. Collagen and HA provide essential support to skin and help it retain its elasticity. The glabellar lines, wrinkles, and lines can be reduced with facial aesthetic treatmen......
  • Frontier Pharma: Orphan and Rare Dermatological Diseases - First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa
    Published: 11-Oct-2018        Price: US 6995 Onwards        Pages: 86
    Orphan and rare dermatological diseases are considerably diverse in terms of pathophysiology, clinical presentation and disease severity. Many of these conditions are extremely debilitating and can even be life-threatening in some cases. Disease visibility can also have a profoundly negative impact on patient confidence. Unmet need within the orphan and rare dermatology market is extremely high with some diseases having no effective treatments. The market is highly genericized and dom......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs